Statistics for Arcus Biosciences (id:9549 RCUS)

Valuation metrics

Market cap

1.35B

Enterprise value

296.79M

Trailing P/E (ttm)

-3.54

Forward P/E

-3.15

PEG ratio

-3.15

Price/Sales (ttm)

5.11

Price/Book (mrq)

2.38

Enterprise Value/Revenue

1.13

Enterprise Value/EBITDA

-1.03

Overview

Shares outstanding

91.51M

Float

51.48M

Shares short

6.65M

% Held by insiders

0.41%

% Held by institutions

0.60%

Average volume (10 days)

625.09K

Average volume (90 days)

Price summary

52-Week low

13.50

52-Week high

20.31

52-Week change

4.35%

Beta

0.89

50-Day moving average

16.43

200-Day moving average

16.39

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-102.66%

Operating margin

-218.75%

Operational effectiveness

Return on assets

-15.25%

Return on equity

-49.77%

Income statement

Revenue (ttm)

3.06

Revenue per share (ttm)

3.06

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-288,000,000.00

Net income to common (ttm)

-270,000,000.00

Diluted EPS (ttm)

-3.19

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.09B

Total cash per share (mrq)

11.90

Total debt (mrq)

79.00M

Total Debt/Equity (mrq)

13.98

Current ratio (mrq)

524.20%

Book value per share (mrq)

6.18

Cash flow

Cash flow statement

-158,000,000.00

Levered free cash flow (LFCF)

-53,500,000.00